Lejárt a biztonsági időkorlát.
Ha az oldal űrlapot is tartalmaz, annak mentése csak érvényes bejelentkezéssel lehetséges.
A bejelentkezés érvényességének meghosszabbításához kérjük lépjen be!
Felhasználó név:
Jelszó:
 

Kiemelt támogatóink

Partnereink

gyógyszeripari információk

AstraZeneca BAYER egis Medtronic Novartis Novo Sandoz Teva

Az MKT legfrissebb hírei


Hírkategória: Összes hírkategória
  • Hungarian survey on Myocardial Infarction: call for participation
    2017.04.03. - MKT - Hírkategória: Általános

    Dear members,

     

    An E-U funded Horizon 2020 project which aims at developing and validating a new imaging technology called Spectral Photon Counting CT (SPCCT) and contrast-media has started last year. SPCCT will allow earlier diagnosis by means of a high spatial resolution combined to the newly developed contrast agent.

    The team of the Erasmus University of Rotterdam (The Netherlands) is working on the cost-effectiveness part of the project and intends to assess the current practice for the diagnosis and treatment pattern of acute MI in Hungary.

    To reach that goal, they have designed a web-based survey targeted at cardiologists thatcan be accessed via the following URL:

    https://docs.google.com/forms/d/1GZYE6oE1ZSIvbz32RlEXl_5RTmhXaN9VAAo7TO0tkKU/viewform?edit_requested=true

     

    Considering the relevance of this research initiative, we would like to invite you, clinical experts, to respond to this survey. Completion will require about 10 minutes.

     

    The anonymous answers will be used as input parameters in the cost–effectiveness models that will be developed.

    The survey results will be sent to the respondents who are willing to provide their contact information.

      

    Thank you all in advance for your collaboration,

    The team of the Erasmus University of Rotterdam, the Netherlands

Vissza